Semnurpharma - Getting back to normalSemnurpharmaSemnurpharmaSemnurpharma

Getting back to normal

  • About
    • Overview
    • Leadership Team
    • Board of Directors
    • Our Culture
  • Partners
  • Chronic Back Pain
    • Chronic Back Pain
    • SP-102 (SEMDEXA™)
    • About our Studies
      • Phase 3 C.L.E.A.R.-2 Study
      • Phase 3 C.L.E.A.R. Study
      • Phase 2 Repeat Dose Study – SP102-03
      • Phase 1 PK/PD and Safety Study – SP-102
      • Pre-Clinical Study – SP-102
  • Science
    • Technology
    • Publications
    • Clinical Trials
  • Investors
    • Investor Overview
    • Presentation
    • News and Events
    • SEC Filings
    • Governance
    • Analyst Coverage
    • Contact Investor Relations
    • Stock Information
  • Join Our Team
  • Contact Us

board-of-directors

26
Sep
Date September 26, 2025

Henry Ji, PhD

Henry Ji brings 25+ years of experience in the biotechnology and life sciences industry. Dr. Ji is c...
Read More
Author uferes@scilexholding.com
26
Sep
Date September 26, 2025

Jaisim Shah

Jaisim Shah has over 30 years industry success in leading product development & commercializing...
Read More
Author uferes@scilexholding.com
26
Sep
Date September 26, 2025

Dorman Followwill

Dorman Followwill was Senior Partner of Transformational Health at Frost & Sullivan, a business cons...
Read More
Author uferes@scilexholding.com
26
Sep
Date September 26, 2025

Alexander Wu, PhD

Yue Alexander Wu is co-founder and CEO of Cothera Bioscience, Inc., a translation medicine and preci...
Read More
Author uferes@scilexholding.com
26
Sep
Date September 26, 2025

Jay Chun, MD, PhD

Jay Chun, M.D., Ph.D., has served as the Chief of Neurosurgery and Director of the Atlantic Health S...
Read More
Author uferes@scilexholding.com
26
Sep
Date September 26, 2025

Annu Navani

Dr. Navani has served as the Chief Executive Officer of Comprehensive Spine and Sports Center since...
Read More
Author uferes@scilexholding.com

 

  • Overview
  • Partners
  • Our Culture
  • Product
  • Publications
  • Join Our Team
  • Presentation
  • Contact Us

Connect, follow and have a conversation with us

  • 960 San Antonio Road, Palo Alto, CA, 94303
  • (650) 422-7515
  • info@semnurpharma.com

Privacy Policy | Terms of Use | © 2026 All rights reserved.

Reference:
@srinipillay 2016:https://www.health.harvard.edu/blog/psychology-low-back-pain-201604259537

… heavy objects, or some other non-specific back injury.

Reference:
@srinipillay 2016: https://www.health.harvard.edu/blog/psychology-low-back-pain-201604259537

The overall estimated number of epidural steroid injection (ESI) procedures in the U.S. is approximately 12.1 million across all Medicare and private coverage patients, with lumbar radiculopathy/sciatica procedures comprising approximately 88% of all ESIs administered, according to a proprietary study by Syneos Health. *

References:
*  Syneos Health

Reference:
@srinipillay 2016: https://www.health.harvard.edu/blog/psychology-low-back-pain-201604259537